IBDEI1L7 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25722,2)
 ;;=^5003219
 ;;^UTILITY(U,$J,358.3,25723,0)
 ;;=F13.988^^92^1174^11
 ;;^UTILITY(U,$J,358.3,25723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25723,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Mild Neurocog D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,25723,1,4,0)
 ;;=4^F13.988
 ;;^UTILITY(U,$J,358.3,25723,2)
 ;;=^5003238
 ;;^UTILITY(U,$J,358.3,25724,0)
 ;;=F13.159^^92^1174^12
 ;;^UTILITY(U,$J,358.3,25724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25724,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Psychotic D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25724,1,4,0)
 ;;=4^F13.159
 ;;^UTILITY(U,$J,358.3,25724,2)
 ;;=^5003196
 ;;^UTILITY(U,$J,358.3,25725,0)
 ;;=F13.259^^92^1174^13
 ;;^UTILITY(U,$J,358.3,25725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25725,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Psychotic D/O w/ Mod-Sev Use D/O
 ;;^UTILITY(U,$J,358.3,25725,1,4,0)
 ;;=4^F13.259
 ;;^UTILITY(U,$J,358.3,25725,2)
 ;;=^5003213
 ;;^UTILITY(U,$J,358.3,25726,0)
 ;;=F13.959^^92^1174^14
 ;;^UTILITY(U,$J,358.3,25726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25726,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,25726,1,4,0)
 ;;=4^F13.959
 ;;^UTILITY(U,$J,358.3,25726,2)
 ;;=^5003232
 ;;^UTILITY(U,$J,358.3,25727,0)
 ;;=F13.181^^92^1174^15
 ;;^UTILITY(U,$J,358.3,25727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25727,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Sexual Dysfunc w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25727,1,4,0)
 ;;=4^F13.181
 ;;^UTILITY(U,$J,358.3,25727,2)
 ;;=^5003198
 ;;^UTILITY(U,$J,358.3,25728,0)
 ;;=F13.281^^92^1174^16
 ;;^UTILITY(U,$J,358.3,25728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25728,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Sexual Dysfunc w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,25728,1,4,0)
 ;;=4^F13.281
 ;;^UTILITY(U,$J,358.3,25728,2)
 ;;=^5003217
 ;;^UTILITY(U,$J,358.3,25729,0)
 ;;=F13.981^^92^1174^17
 ;;^UTILITY(U,$J,358.3,25729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25729,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Sexual Dysfunc w/o Use D/O
 ;;^UTILITY(U,$J,358.3,25729,1,4,0)
 ;;=4^F13.981
 ;;^UTILITY(U,$J,358.3,25729,2)
 ;;=^5003236
 ;;^UTILITY(U,$J,358.3,25730,0)
 ;;=F13.182^^92^1174^18
 ;;^UTILITY(U,$J,358.3,25730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25730,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Sleep D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25730,1,4,0)
 ;;=4^F13.182
 ;;^UTILITY(U,$J,358.3,25730,2)
 ;;=^5003199
 ;;^UTILITY(U,$J,358.3,25731,0)
 ;;=F13.282^^92^1174^19
 ;;^UTILITY(U,$J,358.3,25731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25731,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Sleep D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,25731,1,4,0)
 ;;=4^F13.282
 ;;^UTILITY(U,$J,358.3,25731,2)
 ;;=^5003218
 ;;^UTILITY(U,$J,358.3,25732,0)
 ;;=F13.982^^92^1174^20
 ;;^UTILITY(U,$J,358.3,25732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25732,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Sleep D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,25732,1,4,0)
 ;;=4^F13.982
 ;;^UTILITY(U,$J,358.3,25732,2)
 ;;=^5003237
 ;;^UTILITY(U,$J,358.3,25733,0)
 ;;=F13.129^^92^1174^23
 ;;^UTILITY(U,$J,358.3,25733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25733,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Intox w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25733,1,4,0)
 ;;=4^F13.129
